Marc Tessier-Lavigne - Director at Denali Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
DNLI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Marc Tessier-Lavigne since 10/13/2024

Holdings reported by Marc Tessier-Lavigne for Denali Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.89M $31M $16.44 Jun 3, 2025 Direct
Common Stock 79.2K $1.3M $16.44 Jun 3, 2025 The Tessier-Lavigne/Hynes Irrevocable Trust 2
Common Stock 78.8K $1.3M $16.44 Jun 3, 2025 The Tessier-Lavigne/Hynes Irrevocable Trust 1
Common Stock 78.8K $1.3M $16.44 Jun 3, 2025 The Tessier-Lavigne/Hynes Irrevocable Trust 3
Stock Option (right to buy) 18.1K Jun 3, 2025 Direct Common Stock

Transactions reported by Marc Tessier-Lavigne for Denali Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.